PAG-led Sekhmet Pharmaventures announced the appointment of Sumit Kumar Sahay as Chief Commercial Officer (CCO) and Jitendra Shriram Jalan as Chief Human Resources Officer (CHRO).
Sumit Kumar brings over 24 years of experience across APIs, formulations, and international regulatory environments. His deep expertise spans regulatory issue management, product lifecycle oversight, intellectual property, and ESG initiatives.
Previously, Sumit spent 15 years at Dr. Reddy’s Laboratories and most recently served as CCO at Cohance Lifesciences, where he drove portfolio expansion, optimized business processes and strengthened customer service standards.
Sumit has extensive international business experience across North America, China, North Asia, MENA and other markets. He holds an MBA and has completed the AMP (Advanced Management Programme) at The Wharton School. At Sekhmet, he will lead business development and export growth strategies, leveraging the company’s integrated platform to expand its presence across regulated and semi-regulated markets.
Jitendra Jalan brings over 25 years of multidisciplinary leadership experience spanning Sales, Operations and Human Resources. He has held senior leadership roles at USV, ACC, Endress+Hauser India, Astral Glass and other leading IT organizations. Jitendra is recognized for driving large-scale organizational transformation, strengthening leadership pipelines to support sustainable business growth.
He holds a PGCHRM from XLRI, is SHRM-SCP certified, and an ICF-ACC accredited coach. At Sekhmet, Jitendra will focus on strategic HR business partnering, leadership development and fostering a high-performance, people-centric culture aligned with the company’s global growth ambitions.
Santosh Mahil, Managing Director & CEO of Sekhmet, said, “We are thrilled to welcome Jitendra and Sumit to Sekhmet. As a fully integrated API and CDMO platform through Optimus Pharma and Anjan Drug, we are experiencing strong growth across our API and CDMO business. These appointments enhance both our commercial and operational leadership, enabling us to address evolving global customer needs with agility, expertise and sustainability at the core.”
Nikhil Srivastava, Co-head of Private Equity at PAG, said, “We are delighted to welcome Sumit and Jitendra to the Sekhmet’s leadership. The Sekhmet 2.0 transformation program reflects our commitment to solidifying Sekhmet’s industry leading position. We are confident that the new leadership will accelerate Sekhmet’s progress in advancing its CDMO and API businesses.”
